14.11.2017 18:00:00
|
SpineGuard Announces Its 2018 Financial Calendar
Regulatory News:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that designs, develops and markets disposable medical devices designed to make spine surgery safer, announced today its schedule for the publication of financial information for 2018.
Event | Date* | |
2017 Full-Year Sales | January 4, 2018 | |
2017 Full-Year Results | March 14, 2018 | |
2018 First-Quarter Sales | April 5, 2018 | |
Annual Shareholders Meeting | May 17, 2018 | |
2018 First-Half Sales | July 11, 2018 | |
2018 First-Half Results | September 19, 2018 | |
2018 Third-Quarter Sales | October 5, 2018 |
Note (*): Press releases are published after stock market closes. This information is subject to modification.
Next financial press release: 2016 Full-Year Sales on next January 4, 2018
About SpineGuard®
Founded in 2009 in France and the USA, by
Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine
surgery safer by bringing real-time digital technology into the
operating room. Its primary objective is to establish its proprietary
DSG™ (Dynamic Surgical Guidance) technology as the global standard of
surgical care, starting with safer screw placement in spine surgery and
then in other surgeries. PediGuard®, the first device designed using
DSG, was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D.,
Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is the world’s
first and only handheld device capable of alerting surgeons to potential
pedicular or vertebral breaches. Over 55,000 surgical procedures have
been performed worldwide with DSG™ enabled devices. Numerous studies
published in peer-reviewed medical and scientific journals have
demonstrated the multiple benefits that PediGuard® delivers to patients,
surgical staff and hospitals. Spineguard is expanding the scope of its
DSG™ platform through strategic partnerships with innovative medical
device companies and the development of smart instruments and implants.
SpineGuard has offices in San Francisco and Paris. For further
information, visit www.spineguard.com.
Disclaimer
The SpineGuard securities may not be offered or
sold in the United States as they have not been and will not be
registered under the Securities Act or any United States state
securities laws, and SpineGuard does not intend to make a public offer
of its securities in the United States. This is an announcement and not
a prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy, nor
shall there be any sale of the securities referred to herein in the
United States in which such offer, solicitation or sale would be
unlawful prior to registration or exemption from registration.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171114006015/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Spineguardmehr Nachrichten
Keine Nachrichten verfügbar. |